SMARCA1 and cancer: Given the findings that SWI/SNF complexes contribute to the regulation of enhancer function and, as part of this role, facilitate the acetylation of H3K27, investigation of compounds that alter histone acetylation levels are obviously of interest in the context of SWI/SNF-aberrant cancers [46].